Cellular dissection of psoriasis for transcriptome analyses and the post-GWAS era

BMC Medical Genomics

Volumn 7, Issue 1, 2014, Pages

  Swindell, William R ^a   Stuart, Philip E ^a   Sarkar, Mrinal K ^a   Voorhees, John J ^a   Elder, James T ^a   Johnston, Andrew ^a   Gudjonsson, Johann E ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

AP 1; Fibroblast; GWAS; Keratinocyte; Microarray; Neutrophil; TNFRSF9; Transcription factor

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERFERON REGULATORY FACTOR 1; STAT3 PROTEIN; STAT4 PROTEIN; TRANSCRIPTION FACTOR AP 1; TUMOR NECROSIS FACTOR RECEPTOR; TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY MEMBER 9; UNCLASSIFIED DRUG;

ARTICLE; ATOPIC DERMATITIS; BINDING SITE; BOUTONNEUSE FEVER; CONTROLLED STUDY; GENE EXPRESSION; GENE LOCUS; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; HUMAN; HUMAN CELL; INNATE IMMUNITY; KERATINOCYTE; MACROPHAGE; MAJOR CLINICAL STUDY; NEUTROPHIL; PRIORITY JOURNAL; PSORIASIS; SINGLE NUCLEOTIDE POLYMORPHISM; SKIN FIBROBLAST; SQUAMOUS CELL CARCINOMA; TRANSCRIPTOMICS;

ANTIGENS, CD137; BASE SEQUENCE; BINDING SITES; CLUSTER ANALYSIS; CYTOKINES; FIBROBLASTS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETIC LOCI; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; HUMANS; IMMUNITY, INNATE; KERATINOCYTES; MACROPHAGES; META-ANALYSIS AS TOPIC; MOLECULAR SEQUENCE DATA; NEUTROPHILS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; POLYMORPHISM, SINGLE NUCLEOTIDE; PSORIASIS; RNA, MESSENGER; TRANSCRIPTION FACTORS;

EID: 84903625805     PISSN: None     EISSN: 17558794     Source Type: Journal    
DOI: 10.1186/1755-8794-7-27     Document Type: Article

References (90)

1. Psoriasis and other complex trait dermatoses: from Loci to functional pathways. Capon F, Burden AD, Trembath RC, Barker JN, J Invest Dermatol 2012 132 915 922 10.1038/jid.2011.395 22158561
2. Molecular dissection of psoriasis: integrating genetics and biology. Elder JT, Bruce AT, Gudjonsson JE, Johnston A, Stuart PE, Tejasvi T, Voorhees JJ, Abecasis GR, Nair RP, J Invest Dermatol 2010 130 1213 1226 10.1038/jid.2009.319 19812592
3. Dissecting the psoriasis transcriptome: inflammatory- and cytokine-driven gene expression in lesions from 163 patients. Swindell WR, Johnston A, Voorhees JJ, Elder JT, Gudjonsson JE, BMC Genomics 2013 14 527 10.1186/1471-2164-14-527 23915137
4. Meta-analysis derived (MAD) transcriptome of psoriasis defines the "core" pathogenesis of disease. Tian S, Krueger JG, Li K, Jabbari A, Brodmerkel C, Lowes MA, Suárez-Fariñas M, PLoS One 2012 7 44274 10.1371/journal.pone.0044274 22957057
5. The mechanistic basis for psoriasis immunopathogenesis: translating genotype to phenotype. Report of a workshop, Venice, 2012. Bachelez H, Viguier M, Tebbey PW, Lowes M, Suárez-Fariñas M, Costanzo A, Nestle FO, Br J Dermatol 2013 169 283 286 10.1111/bjd.12347 23941252
6. Heterogeneity of inflammatory and cytokine networks in chronic plaque psoriasis. Swindell WR, Xing X, Stuart PE, Chen CS, Aphale A, Nair RP, Voorhees JJ, Elder JT, Johnston A, Gudjonsson JE, PLoS One 2012 7 34594 10.1371/journal.pone.0034594 22479649
7. Integrating autoimmune risk loci with gene-expression data identifies specific pathogenic immune cell subsets. Hu X, Kim H, Stahl E, Plenge R, Daly M, Raychaudhuri S, Am J Hum Genet 2011 89 496 506 10.1016/j.ajhg.2011.09.002 21963258
8. Coordinating GWAS results with gene expression in a systems immunologic paradigm in autoimmunity. Stranger BE, De Jager PL, Curr Opin Immunol 2012 24 544 551 10.1016/j.coi.2012.09.002 23040211
9. Getting under the skin: the immunogenetics of psoriasis. Bowcock AM, Krueger JG, Nat Rev Immunol 2005 5 699 711 10.1038/nri1689 16138103 (Pubitemid 43090738)
10. Skin innate immune system in psoriasis: friend or foe? Nickoloff BJ, J Clin Invest 1999 104 1161 1164 10.1172/JCI8633 10545511 (Pubitemid 29536283)
11. Genetics of psoriasis: evidence for epistatic interaction between skin barrier abnormalities and immune deviation. Bergboer JG, Zeeuwen PL, Schalkwijk J, J Invest Dermatol 2012 132 2320 2321 10.1038/jid.2012.167 22622420
12. Abnormal epidermal barrier in the pathogenesis of psoriasis. Wolf R, Orion E, Ruocco E, Ruocco V, Clin Dermatol 2012 30 323 328 22507047
13. Psoriasis genetics: breaking the barrier. Roberson ED, Bowcock AM, Trends Genet 2010 26 415 423 10.1016/j.tig.2010.06.006 20692714
14. Psoriasis: dysregulation of innate immunity. Bos JD, de Rie MA, Teunissen MB, Piskin G, Br J Dermatol 2005 152 1098 1107 10.1111/j.1365-2133.2005.06645.x 15948970 (Pubitemid 40933406)
15. History of the treatment of psoriasis. Farber EM, J Am Acad Dermatol 1992 27 640 645 10.1016/0190-9622(92)70232-5 1401327
16. Psoriasis treatment-yesterday, today, and tomorrow. Gruber F, Kastelan M, Brajac I, Acta Dermatovenerol Croat 2004 12 30 34 15072746
17. Cyclosporine improves psoriasis in a double-blind study. Ellis CN, Gorsulowsky DC, Hamilton TA, Billings JK, Brown MD, Headington JT, Cooper KD, Baadsgaard O, Duell EA, Annesley TM, Turcotte JG, Voorhees JJ, JAMA 1986 256 3110 3116 10.1001/jama.1986.03380220076026 3023712 (Pubitemid 17045825)
18. Genetics of Psoriasis and Pharmacogenetics of Biological Drugs. Prieto-Pérez R, Cabaleiro T, Daudén E, Ochoa D, Roman M, Abad-Santos F, Autoimmune Dis 2013 2013 613086 24069534
19. Spontaneous development of psoriasis in a new animal model shows an essential role for resident T cells and tumor necrosis factor-alpha. Boyman O, Hefti HP, Conrad C, Nickoloff BJ, Suter M, Nestle FO, J Exp Med 2004 199 731 736 10.1084/jem.20031482 14981113 (Pubitemid 38316440)
20. Melanocyte as a possible key cell in the pathogenesis of psoriasis vulgaris. Brajac I, Kastelan M, Prpić-Massari L, Perisa D, Loncarek K, Malnar D, Med Hypotheses 2009 73 254 256 10.1016/j.mehy.2009.01.048 19307064
21. Innate immunity in the pathogenesis of psoriasis. Sweeney CM, Tobin AM, Kirby B, Arch Dermatol Res 2011 303 691 705 10.1007/s00403-011-1169-1 21863252
22. A subpopulation of CD163-positive macrophages is classically activated in psoriasis. Fuentes-Duculan J, Suárez-Fariñas M, Zaba LC, Nograles KE, Pierson KC, Mitsui H, Pensabene CA, Kzhyshkowska J, Krueger JG, Lowes MA, J Invest Dermatol 2010 130 2412 2422 10.1038/jid.2010.165 20555352
23. Skewed distribution of natural killer cells in psoriasis skin lesions. Batista MD, Ho EL, Kuebler PJ, Milush JM, Lanier LL, Kallas EG, York VA, Chang D, Liao W, Unemori P, Leslie KS, Maurer T, Nixon DF, Exp Dermatol 2013 22 64 66 10.1111/exd.12060 23278897
24. Role of neutrophils in induction of acute inflammation in T-cell-mediated immune dermatosis, psoriasis: a neutrophil-associated inflammation-boosting loop. Terui T, Ozawa M, Tagami H, Exp Dermatol 2000 9 1 10 10.1034/j.1600-0625. 2000.009001001.x 10688368 (Pubitemid 30093030)
25. Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease. Jostins L, Ripke S, Weersma RK, Duerr RH, McGovern DP, Hui KY, Lee JC, Schumm LP, Sharma Y, Anderson CA, Essers J, Mitrovic M, Ning K, Cleynen I, Theatre E, Spain SL, Raychaudhuri S, Goyette P, Wei Z, Abraham C, Achkar JP, Ahmad T, Amininejad L, Ananthakrishnan AN, Andersen V, Andrews JM, Baidoo L, Balschun T, Bampton PA, Bitton A, et al. Nature 2012 491 119 124 10.1038/nature11582 23128233
26. Identification of 15 new psoriasis susceptibility loci highlights the role of innate immunity. Tsoi LC, Spain SL, Knight J, Ellinghaus E, Stuart PE, Capon F, Ding J, Li Y, Tejasvi T, Gudjonsson JE, Kang HM, Allen MH, McManus R, Novelli G, Samuelsson L, Schalkwijk J, Ståhle M, Burden AD, Smith CH, Cork MJ, Estivill X, Bowcock AM, Krueger GG, Weger W, Worthington J, Tazi-Ahnini R, Nestle FO, Hayday A, Hoffmann P, Winkelmann J, et al. Nat Genet 2012 44 1341 1348 10.1038/ng.2467 23143594
27. Genome-wide scan reveals association of psoriasis with IL-23 and NF-kappaB pathways. Nair RP, Duffin KC, Helms C, Ding J, Stuart PE, Goldgar D, Gudjonsson JE, Li Y, Tejasvi T, Feng BJ, Ruether A, Schreiber S, Weichenthal M, Gladman D, Rahman P, Schrodi SJ, Prahalad S, Guthery SL, Fischer J, Liao W, Kwok PY, Menter A, Lathrop GM, Wise CA, Begovich AB, Voorhees JJ, Elder JT, Krueger GG, Bowcock AM, Abecasis GR, et al. Nat Genet 2009 41 199 204 10.1038/ng.311 19169254
28. Type I interferon: potential therapeutic target for psoriasis? Yao Y, Richman L, Morehouse C, de los Reyes M, Higgs BW, Boutrin A, White B, Coyle A, Krueger J, Kiener PA, Jallal B, PLoS One 2008 3 2737 10.1371/journal.pone. 0002737 18648529
29. Expanding the Psoriasis Disease Profile: Interrogation of the Skin and Serum of Patients with Moderate-to-Severe Psoriasis. Suárez-Fariñas M, Li K, Fuentes-Duculan J, Hayden K, Brodmerkel C, Krueger JG, J Invest Dermatol 2012 132 2552 2564 10.1038/jid.2012.184 22763790
30. Cross-study homogeneity of psoriasis gene expression in skin across a large expression range. Bigler J, Rand HA, Kerkof K, Timour M, Russell CB, PLoS One 2013 8 52242 10.1371/journal.pone.0052242 23308107
31. Early tissue responses in psoriasis to the anti-TNF- biologic etanercept suggest reduced IL-17R expression and signalling. Johnston A, Guzman AM, Swindell WR, Wang F, Kang S, Gudjonsson JE, Br J Dermatol 2014 In Press
32. Potential etiologic and functional implications of genome-wide association loci for human diseases and traits. Hindorff LA, Sethupathy P, Junkins HA, Ramos EM, Mehta JP, Collins FS, Manolio TA, Proc Natl Acad Sci U S A 2009 106 9362 9367 10.1073/pnas.0903103106 19474294
33. A navigator for human genome epidemiology. Yu W, Gwinn M, Clyne M, Yesupriya A, Khoury MJ, Nat Genet 2008 40 124 125 10.1038/ng0208-124 18227866 (Pubitemid 351171407)
34. Suppression of progenitor differentiation requires the long noncoding RNA ANCR. Kretz M, Webster DE, Flockhart RJ, Lee CS, Zehnder A, Lopez-Pajares V, Qu K, Zheng GX, Chow J, Kim GE, Rinn JL, Chang HY, Siprashvili Z, Khavari PA, Genes Dev 2012 26 338 343 10.1101/gad.182121.111 22302877
35. Genomic profiling of a human organotypic model of AEC syndrome reveals ZNF750 as an essential downstream target of mutant TP63. Zarnegar BJ, Webster DE, Lopez-Pajares V, Vander Stoep Hunt B, Qu K, Yan KJ, Berk DR, Sen GL, Khavari PA, Am J Hum Genet 2012 91 435 443 10.1016/j.ajhg.2012.07.007 22922031
36. GRHL3/GET1 and trithorax group members collaborate to activate the epidermal progenitor differentiation program. Hopkin AS, Gordon W, Klein RH, Espitia F, Daily K, Zeller M, Baldi P, Andersen B, PLoS Genet 2012 8 1002829 10.1371/journal.pgen.1002829 22829784
37. A subset of methylated CpG sites differentiate psoriatic from normal skin. Roberson ED, Liu Y, Ryan C, Joyce CE, Duan S, Cao L, Martin A, Liao W, Menter A, Bowcock AM, J Invest Dermatol 2012 132 583 592 10.1038/jid.2011.348 22071477
38. Analysis of high density expression microarrays with signed-rank call algorithms. Liu WM, Mei R, Di X, Ryder TB, Hubbell E, Dee S, Webster TA, Harrington CA, Ho MH, Baid J, Smeekens SP, Bioinformatics 2002 18 1593 1599 10.1093/bioinformatics/18.12.1593 12490443 (Pubitemid 36097724)
39. Preferential Binding to Elk-1 by SLE-Associated IL10 Risk Allele Upregulates IL10 Expression. Sakurai D, Zhao J, Deng Y, Kelly JA, Brown EE, Harley JB, Bae SC, Alarcn-Riquelme ME, Edberg JC, Kimberly RP, Ramsey-Goldman R, Petri MA, Reveille JD, Vilá LM, Alarcón GS, Kaufman KM, Vyse TJ, Jacob CO, Gaffney PM, Sivils KM, James JA, Kamen DL, Gilkeson GS, Niewold TB, Merrill JT, Scofield RH, Criswell LA, Stevens AM, Boackle SA, BIOLUPUS and GENLES networks, et al. PLoS Genet 2013 9 1003870 10.1371/journal.pgen.1003870 24130510
40. The identification of trans-acting factors that regulate the expression of GDF5 via the osteoarthritis susceptibility SNP rs143383. Syddall CM, Reynard LN, Young DA, Loughlin J, PLoS Genet 2013 9 1003557 10.1371/journal.pgen.1003557 23825960
41. Proteome-wide analysis of disease-associated SNPs that show allele-specific transcription factor binding. Butter F, Davison L, Viturawong T, Scheibe M, Vermeulen M, Todd JA, Mann M, PLoS Genet 2012 8 1002982 10.1371/journal.pgen.1002982 23028375
42. Transcriptome Analysis of Psoriasis in A Large Case-control Sample: Rna-Seq Provides Insights Into Disease Mechanisms. Li B, Tsoi LC, Swindell WR, Gudjonsson JE, Tejasvi T, Johnston A, Ding J, Stuart PE, Xing X, Kochkodan JJ, Voorhees JJ, Kang HM2, Nair RP, Abecasis GR, Elder JT, J Invest Dermatol In Press
43. Angiogenesis drives psoriasis pathogenesis. Heidenreich R, Röcken M, Ghoreschi K, Int J Exp Pathol 2009 90 232 248 10.1111/j.1365-2613.2009.00669.x 19563608
44. Interleukin-1 and interleukin-6 in psoriasis. Prens EP, Benne K, van Damme J, Bakkus M, Brakel K, Benner R, van Joost T, J Invest Dermatol 1990 95 121S 124S 10.1111/1523-1747.ep12874991 2258628
45. Interleukin-8 is induced in skin equivalents and is highest in those derived from psoriatic fibroblasts. Konstantinova NV, Duong DM, Remenyik E, Hazarika P, Chuang A, Duvic M, J Invest Dermatol 1996 107 615 621 10.1111/1523-1747.ep12584215 8823370 (Pubitemid 26338589)
46. Paracrine regulation of keratinocyte proliferation and differentiation. Werner S, Smola H, Trends Cell Biol 2001 11 143 146 10.1016/S0962-8924(01)01955- 9 11306276 (Pubitemid 32295911)
47. Combined use of laser capture microdissection and cDNA microarray analysis identifies locally expressed disease-related genes in focal regions of psoriasis vulgaris skin lesions. Mitsui H, Suárez-Fariñas M, Belkin DA, Levenkova N, Fuentes-Duculan J, Coats I, Fujita H, Krueger JG, J Invest Dermatol 2012 132 1615 1626 10.1038/jid.2012.33 22402443
48. The multitasking organ: recent insights into skin immune function. Di Meglio P, Perera GK, Nestle FO, Immunity 2011 35 857 869 10.1016/j.immuni.2011. 12.003 22195743
49. Bimodal immune activation in psoriasis. Christophers E, Metzler G, Röcken M, Br J Dermatol 2014 170 59 65 10.1111/bjd.12631 24117368
50. Intraepidermal accumulation of polymorphonuclear leukocytes in chronic stable plaque psoriasis. van de Kerkhof PC, Lammers AM, Dermatologica 1987 174 224 227 10.1159/000249184 3582707 (Pubitemid 17052565)
51. Rapid improvement of psoriasis vulgaris during drug-induced agranulocytosis. Toichi E, Tachibana T, Furukawa F, J Am Acad Dermatol 2000 43 391 395 10.1067/mjd.2000.103264 10901732 (Pubitemid 30636548)
52. Decrease in neutrophils observed in vivo in psoriatics after PUVA therapy. Dahl KB, Nyfors A, Brodthagen H, Arch Dermatol Res 1978 262 131 134 10.1007/BF00455580 686817
53. Granulocyte and monocyte adsorption apheresis for refractory skin diseases due to activated neutrophils, psoriasis, and associated arthropathy. Sakanoue M, Takeda K, Kawai K, Kanekura T, Ther Apher Dial 2013 17 477 483 24107275
54. Mast cells and neutrophils release IL-17 through extracellular trap formation in psoriasis. Lin AM, Rubin CJ, Khandpur R, Wang JY, Riblett M, Yalavarthi S, Villanueva EC, Shah P, Kaplan MJ, Bruce AT, J Immunol 2011 187 490 500 10.4049/jimmunol.1100123 21606249
55. Psoriatic keratinocytes prime neutrophils for an overproduction of superoxide anions. Guérard S, Allaeys I, Martin G, Pouliot R, Poubelle PE, Arch Dermatol Res 2013 305 879 889 10.1007/s00403-013-1404-z 23974213
56. Cytokine-induced CEACAM1 expression on keratinocytes is characteristic for psoriatic skin and contributes to a prolonged lifespan of neutrophils. Rahmoun M, Molès JP, Pedretti N, Mathieu M, Fremaux I, Raison-Peyron N, Lecron JC, Yssel H, Pène J, J Invest Dermatol 2009 129 671 681 10.1038/jid.2008.303 18843289
57. Expression of HLA-DR (major histocompatibility complex class II) on neutrophils from patients treated with granulocyte-macrophage colony-stimulating factor for mobilization of stem cells. Mudzinski SP, Christian TP, Guo TL, Cirenza E, Hazlett KR, Gosselin EJ, Blood 1995 86 2452 2453
58. In vivo induction of HLA-DR on human neutrophils in patients treated with interferon-gamma. Reinisch W, Tillinger W, Lichtenberger C, Gangl A, Willheim M, Scheiner O, Steger G, Blood 1996 87 3068 8639936 (Pubitemid 26102266)
59. Induction of MHC class II on human polymorphonuclear neutrophils by granulocyte/macrophage colony-stimulating factor, IFN-gamma, and IL-3. Gosselin EJ, Wardwell K, Rigby WF, Guyre PM, J Immunol 1993 151 1482 1490 8335942 (Pubitemid 23219286)
60. Secretory leukocyte proteinase inhibitor-competent DNA deposits are potent stimulators of plasmacytoid dendritic cells: implication for psoriasis. Skrzeczynska-Moncznik J, Wlodarczyk A, Zabieglo K, Kapinska-Mrowiecka M, Marewicz E, Dubin A, Potempa J, Cichy J, J Immunol 2012 189 1611 1617 10.4049/jimmunol.1103293 22786767
61. Proteins derived from neutrophil extracellular traps may serve as self-antigens and mediate organ damage in autoimmune diseases. Knight JS, Carmona-Rivera C, Kaplan MJ, Front Immunol 2012 3 380 23248629
62. Neutrophil extracellular chromatin traps connect innate immune response to autoimmunity. Radic M, Marion TN, Semin Immunopathol 2013 35 465 480 10.1007/s00281-013-0376-6 23595413
63. New psoriasis susceptibility genes: momentum for skin-barrier disruption. Coto E, Santos-Juanes J, Coto-Segura P, Alvarez V, J Invest Dermatol 2011 131 1003 1005 10.1038/jid.2011.14 21494239
64. Intracellular pathogen detection by RIG-I-like receptors. Dixit E, Kagan JC, Adv Immunol 2013 117 99 125 23611287
65. Modulation of epidermal transcription circuits in psoriasis: New links between inflammation and hyperproliferation. Swindell WR, Johnston A, Xing X, Voorhees JJ, Elder JT, Gudjonsson JE, PLoS One 2013 8 79253 10.1371/journal. pone.0079253 24260178
66. Double-stranded RNA induces an antiviral defense status in epidermal keratinocytes through TLR3-, PKR-, and MDA5/RIG-I-mediated differential signaling. Kalali BN, Köllisch G, Mages J, Müller T, Bauer S, Wagner H, Ring J, Lang R, Mempel M, Ollert M, J Immunol 2008 181 2694 2704 10.4049/jimmunol.181.4.2694 18684960
67. IFN-alpha enhances poly-IC responses in human keratinocytes by inducing expression of cytosolic innate RNA receptors: relevance for psoriasis. Prens EP, Kant M, van Dijk G, van der Wel LI, Mourits S, van der Fits L, J Invest Dermatol 2008 128 932 938 10.1038/sj.jid.5701087 17928888 (Pubitemid 351374290)
68. Activation of an immunoregulatory and antiviral gene expression program in poly(I:C)-transfected human neutrophils. Tamassia N, Le Moigne V, Rossato M, Donini M, McCartney S, Calzetti F, Colonna M, Bazzoni F, Cassatella MA, J Immunol 2008 181 6563 6573 10.4049/jimmunol.181.9.6563 18941247
69. Beyond GWASs: illuminating the dark road from association to function. Edwards SL, Beesley J, French JD, Dunning AM, Am J Hum Genet 2013 93 779 797 10.1016/j.ajhg.2013.10.012 24210251
70. From genome-wide association studies to disease mechanisms: celiac disease as a model for autoimmune diseases. Kumar V, Wijmenga C, Withoff S, Semin Immunopathol 2012 34 567 580 10.1007/s00281-012-0312-1 22580835
71. Regulation of mouse 4-1BB expression: multiple promoter usages and a splice variant. Kim JD, Kim CH, Kwon BS, Mol Cells 2011 31 141 149 10.1007/s10059-011-0018-6 21347708
72. NF-kappaB and AP-1 regulate activation-dependent CD137 (4-1BB) expression in T cells. Kim JO, Kim HW, Baek KM, Kang CY, FEBS Lett 2003 541 163 170 10.1016/S0014-5793(03)00326-0 12706838 (Pubitemid 36428936)
73. ILA, a member of the human nerve growth factor/tumor necrosis factor receptor family, regulates T-lymphocyte proliferation and survival. Schwarz H, Blanco FJ, von Kempis J, Valbracht J, Lotz M, Blood 1996 87 2839 2845 8639902 (Pubitemid 26102233)
74. 4-1BB signaling beyond T cells. Vinay DS, Kwon BS, Cell Mol Immunol 2011 8 281 284 10.1038/cmi.2010.82 21217771
75. Evidence for a pro-apoptotic function of CD137 in granulocytes. Simon HU, Swiss Med Wkly 2001 131 455 458 11641968
76. CD137 activation abrogates granulocyte-macrophage colony-stimulating factor-mediated anti-apoptosis in neutrophils. Heinisch IV, Daigle I, Knöpfli B, Simon HU, Eur J Immunol 2000 30 3441 3446 10.1002/1521- 4141(2000012)30:12<3441::AID-IMMU3441>3.0.CO;2-L 11093162 (Pubitemid 32005215)
77. Quality assessment of Affymetrix GeneChip Data. Bolstad BM, Collin F, Brettschneider J, Simpson K, Cope L, Irizarry RA, Speed TP, Bioinformatics and Computational Biology Solutions using R and Bioconductor New York: Springer, Gentleman R, Carey V, Huber W, Irizarry R, Dudoit S, 2005 33 47
78. Interpretation of multiple probe sets mapping to the same gene in Affymetrix GeneChips. Stalteri MA, Harrison AP, BMC Bioinformatics 2007 8 13 10.1186/1471-2105-8-13 17224057 (Pubitemid 46242717)
79. Design and Performance of the GeneChip® Human Genome U133 Plus 2.0 and Human Genome U133A 2.0 Arrays. Affymetrix Technical Note, http://media.affymetrix.com/support/technical/technotes/hgu133-p2-technote.pdf
80. Controlling the false discovery rate: a powerful and practical approach to multiple testing. Benjamini Y, Hochberg Y, J Roy Stat Soc B 1995 57 289 300
81. Robust shifts in S100a9 expression with aging: a novel mechanism for chronic inflammation. Swindell WR, Johnston A, Xing X, Little A, Robichaud P, Voorhees JJ, Fisher G, Gudjonsson JE, Sci Rep 2013 3 1215 23386971
82. Indicators of "healthy aging" in older women (65-69 years of age). A data-mining approach based on prediction of long-term survival. Swindell WR, Ensrud KE, Cawthon PM, Cauley JA, Cummings SR, Miller RA, Study Of Osteoporotic Fractures Research Group, BMC Geriatr 2010 10 55 20716351
83. JASPAR 2010: the greatly expanded open-access database of transcription factor binding profiles. Portales-Casamar E, Thongjuea S, Kwon AT, Arenillas D, Zhao X, Valen E, Yusuf D, Lenhard B, Wasserman WW, Sandelin A, Nucleic Acids Res 2010 38 105 D110 10.1093/nar/gkp950 19906716
84. UniPROBE, update 2011: expanded content and search tools in the online database of protein-binding microarray data on protein-DNA interactions. Robasky K, Bulyk ML, Nucleic Acids Res 2011 39 124 D128 10.1093/nar/gkq992 21037262
85. Analysis of variation at transcription factor binding sites in Drosophila and humans. Spivakov M, Akhtar J, Kheradpour P, Beal K, Girardot C, Koscielny G, Herrero J, Kellis M, Furlong EE, Birney E, Genome Biol 2012 13 49 10.1186/gb-2012-13-9-r49 22950968
86. hPDI: a database of experimental human protein-DNA interactions. Xie Z, Hu S, Blackshaw S, Zhu H, Qian J, Bioinformatics 2010 26 287 289 10.1093/bioinformatics/btp631 19900953
87. TRANSFAC and its module TRANSCompel: transcriptional gene regulation in eukaryotes. Matys V, Kel-Margoulis OV, Fricke E, Liebich I, Land S, Barre-Dirrie A, Reuter I, Chekmenev D, Krull M, Hornischer K, Voss N, Stegmaier P, Lewicki-Potapov B, Saxel H, Kel AE, Wingender E, Nucleic Acids Res 2006 34 108 D110 10.1093/nar/gkj143 16381825
88. PLINK: a tool set for whole-genome association and population-based linkage analyses. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, Bender D, Maller J, Sklar P, de Bakker PI, Daly MJ, Sham PC, Am J Hum Genet 2007 81 559 575 10.1086/519795 17701901 (Pubitemid 47330214)
89. EGFR and IL-1 signaling synergistically promote keratinocyte antimicrobial defenses in a differentiation-dependent manner. Johnston A, Gudjonsson JE, Aphale A, Guzman AM, Stoll SW, Elder JT, J Invest Dermatol 2011 131 329 337 10.1038/jid.2010.313 20962853
90. Susceptibility-associated genetic variation at IL12B enhances Th1 polarization in psoriasis. Johnston A, Xing X, Swindell WR, Kochkodan J, Riblett M, Nair RP, Stuart PE, Ding J, Voorhees JJ, Elder JT, Gudjonsson JE, Hum Mol Genet 2013 22 1807 1815 10.1093/hmg/ddt034 23376980